No other significant improvements were noted in anthropometric measures (weight, body mass index [BMI], adipose tissue area), lipid profiles (TC, TG, high-density lipoprotein cholesterol [HDL-C], free fatty acids [FFA]), glycemic indicators (HbA1c, glucose, insulin, homeostatic model assessment of insulin resistance [HOMA-IR]), or exploratory biomarkers (high-sensitivity C-reactive protein [HsCRP], ghrelin, growth hormone [GH], insulin-like growth factor 1 [IGF-1]) (26, 27) (as detailed in Table 4). The gene discussed is GH1; the disease is Insulin resistance.